CD19 expression in acute leukemia is not restricted to the cytogenetically aberrant populations

Author： Francis Jawad  

Publisher： Informa Healthcare

ISSN： 1042-8194

Source： Leukemia and Lymphoma, Vol.54, Iss.7, 2013-07, pp. : 1517-1520

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Syndecan-1 (CD138) Expression in Acute Myeloblastic Leukemia Cells

By Seftalioglu Aysel   Seftalioglu Aysel   Seftalioglu Aysel   Seftalioglu Aysel   Seftalioglu Aysel   Seftalioglu Aysel   Seftalioglu Aysel   Seftalioglu Aysel   Seftalioglu Aysel   Seftalioglu Aysel  

Acta Oncologica, Vol. 42, Iss. 1, 2003-01 ,pp. : 71-74

Informa Healthcare

Access to resources Recommend Favorite

Aberrant expression of Treg-associated cytokine IL-35 along with IL-10 and TGF-β in acute myeloid leukemia

By                

Oncology Letters, Vol. 3, Iss. 5, 2012-01 ,pp. : 1119-1123

Spandidos Publications

Access to resources Recommend Favorite

Prognostic value of the expression of phosphatase and tensin homolog and CD44 in elderly patients with refractory acute myeloid leukemia

By          

Oncology Letters, Vol. 10, Iss. 1, 2015-01 ,pp. : 103-110

Spandidos Publications

Access to resources Recommend Favorite

Implications of lipocalin 2 expression in acute myeloid leukemia

By Frankfurt Olga   Platanias Leonidas C.  

Leukemia and Lymphoma, Vol. 54, Iss. 8, 2013-08 ,pp. : 1573-1574

Informa Healthcare

Access to resources Recommend Favorite

CD1d levels in peripheral blood of patients with acute myeloid leukemia and acute lymphoblastic leukemia

By                  

Oncology Letters, Vol. 8, Iss. 2, 2014-01 ,pp. : 825-830

Spandidos Publications

Access to resources Recommend Favorite